A neuroblastoma X glioma hybrid cell line with well-developed neural properties was found that has high-affinity morphine receptors. The average cell contains approximately 3 X 105 receptors. In contrast, parent cells and other neuroblastoma or hybrid cell lines tested had few or no morphine receptors.
Membrane preparations that bind narcotic analgesics such as morphine and its congeners have been described by a number of laboratories (1) (2) (3) (4) (5) (6) (7) (8) (9) . Such binding satisfies the criteria first enunciated by Goldstein et al. (10) for a narcotic receptor in that it is specific for the pharmacologically active D (-) enantiomers of the narcotics. Furthermore, there is a generally satisfactory correlation between binding affinities measured for various opiates and their potencies as analgesics in vivo (5) as well as a somewhat more satisfactory correlation between binding strength and narcotic agonist potency measured with isolated intestinal preparations (11) . The membrane preparations studied to date were isolated from brain or intestine and, therefore, are derived from mixtures of cell types. We hoped to obtain a relatively homogenous cell population for our studies of opiate action by examining clonal lines of neuroblastoma cells (12) for morphine receptors. Somatic cell hybrids also were studied, since previous results showed that genes for neural properties can be activated (13) or deactivated (14) in hybrids formed by the fusion of neuroblastoma cells with other cell types. New phenotypes thus generated can be inherited and thereby perpetuated in a fairly stable fashion.
In this report, we wish to describe cell lines with and without morphine receptors.
MATERIALS AND METHODS
Chemicals were obtained from the following sources: [3H Idihydromorphine (51.6 Ci/mmole) from New England Nuclear Corp.; morphine sulfate from Merck and Co.; naloxone hydrochloride was donated by Endo Laboratories, Inc.; the other narcotics used were kindly supplied by Dr. Everette May; fetal bovine serum was from Colorado Serum Co.; DMEM (Dulbecco-Vogt modification of Eagle's minimal essential medium) was from GIBCO (Catalogue no. H21). Other chemicals were of reagent grade purity.
Cell Lines. The neuroblastoma cell lines used were derived from the mouse C-1300 tumor; their properties have been described previously (12) . Neuroblastoma X glioma hybrids, NG108-5 and NG108-15, were obtained* by Sendai virus-induced fusion of neuroblastoma clone N18TG-2, resistant to 6-thioguanine (14) , and C6Bu-1, a 5-bromodeoxyuridine-resistant clone of the rat glioma C6 (15) . Clone NL1F is a hybrid formed by fusion of neuroblastoma clone N4TG1 and mouse L cell clone B82 (14) .
Neuroblastoma and C6Bu-1 cells were grown in petri dishes or flasks in 90% DMEM, 10% fetal bovine serum, in a humidified atmosphere of 90% air, 10% C02, and 370 as described (12) . Hybrid cells were grown in the same medium supplemented with 0.1 mM hypoxanthine, 1 MM aminopterin, and 12 ,MM thymidine. For drug binding experiments, the cells usually were grown to confluency and harvested by scraping (from petri dishes) or shaking (from flasks) in their growth medium. The cells were centrifuged at approximately 500 X g for 5 min at room temperature and the pellets (generally less than 1 ml) were washed two times with 50 ml of D1 [137 mM NaCl, 5.4 mM KCl, 0.17 mM Na2HPO4, 0.22 mM KH2PO4, 5.5 mM glucose (16) 19 ,000 rpm (45,000 X g) for 10 min in a Sorvall RC2B centrifuge at 00 and supernatant fluids were removed with a 5-ml syringe equipped with a blunt 19-gauge needle and then discarded. Each tube and surface of the pellet was washed with 1 ml of 0.32 M sucrose and the washed pellet was suspended in 1 ml of 1% Triton X-100 and assayed for radioactivity after mixing with 7.5 ml of Triton-toluene scintillation fluid (17) . All Fig. 1 is considered to be specific binding. The specific binding sites discriminate between (+) and (-) enantiomers of the narcotics as shown for the pair dextrorphan and levorphanol in Fig. 2 . The latter compound is seen to displace specifically bound dihydromorphine at concentrations more than two orders of magnitude lower than does its analgesically inactive enantiomer, dextrorphan (18) . A similar result has been obtained with the (-) and (+) enantiomers of metazocine, the latter of which is inactive as an analgesic (19) and as a displacer of dihydromorphine, at least at concentrations of pM and below.
The number of binding sites present in suspensions of NG108-15 can be estimated. by measuring the amount of specific binding as a function of [3H Idihydromorphine concentration. We find that, at saturation, approximately 0.6 pmoles of dihydromorphine are bound specifically per mg of cell protein (Fig. 3) . The insert to the Figure shows plotted according to Scatchard (20) and is consistent with there being only one class of dihydromorphine binding site with a dissociation constant of 20-30 nM.
We have examined the ability of a number of other narcotic analgesics as well as of the specific antagonist, naloxone, to bind to the receptors found in NG108-15 suspensions, as measured by their ability to displace specifically bound [3H]dihydromorphine. In Table 2 the binding affinities measured in this way with NG108-15 suspensions and also with-a crude mitochondrial fraction of rat brain as the source of receptors are shown. Note that the binding affinities of the NG108-15 preparations are generally somewhat lower than those of the brain preparation, but that the relative binding strengths are similar in the two preparations. The order of binding affinities is seen to be well correlated with the affinities found by Kosterlitz and Watt (11) for the pharmacological action of these agents on segments of guinea pig ileum.
An important question concerns the location of the narcotic receptor sites. Trypsin is often used as an aid in detaching Klee, unpublished observations.) c These are apparent dissociation constants (nM) for the antagonist activity of these compounds in the isolated ileum (11) . Many properties of neuronal cell lines in culture have been shown to be regulated (22) . Thus, the specific activities of choline acetyl transferase and cholinesterase* as well as the extent of morphological differentiation of NG108-15 cells can be increased many-fold in cultures which are-grown in the presence of dibutyryl cAMP or are maintained in stationary phase (21) . We did not detect regulation of the number of morphine receptor sites, since logarithmically dividing NG-108-15 cells had the same number of morphine receptors as sister cultures maintained in the presence of dibutyryl cAMP that were highly differentiated with resp ct to cell morphology. On the other hand, we observed with one population of NG108&15 that the cells lost much of their ability to bind dihydromorphine in a specific manner after 19 to 20 subcultures. Thus, it should be possible to obtain defective cell lines with respect to the synthesis, structure, or function of morphine receptors.
At saturation of dihydromorphine we estimate that there are 0.6 pmoles of bound morphine per mg of cell protein. This is approximately twice the specific activity of rat brain homogenates measured under identical conditions. Since 1 mg of protein corresponds to about 1.2 X 106 cells, there are approximately 300,000 receptor sites per cell. This is a large number and is similar to the number of nicotinic acetylcholine receptors'of cultured'sympathetic ganglion neurons of the chick (23) .
One mechanism that has been proposed for the action of morphine is to inhibit the release of acetylcholine (24) . Since NG108-15'cells both synthesize acetylcholine and release this compound into the medium, it should be possible to test this hypothesis. In addition, the recent demonstration by Collier and Roy of the specific reversal by narcotic analgesics of prostaglandin 'E-stimulated cAMP formation in rat brain homogenates (25) provides a possible mechanism for the action of these drugs. In collaboration with Shail K. Sharma, we have confirmed these findings with homogenates prepared from NG10S-15, in that morphine was found to inhibit adenylate cyclase activity of NG108-15.
The availability of relatively homogeneous populations of cells with and without morphine receptors and with other neuronal properties provides opportunities to explore questions relating to the mechanism of action of morphine and, Morphine Receptors in Neural Cell Lines 3477 possibly, phenomena such as morphine dependence and tolerance.
